rolpryna ep 2 mg
krka d.d., novo mesto - slovenia - clopidogrelum - compr. cu elib. prel. - 2 mg - agenti dopaminergici agonisti dopaminergici
rolpryna ep 4 mg
krka d.d., novo mesto - slovenia - clopidogrelum - compr. cu elib. prel. - 4 mg - agenti dopaminergici agonisti dopaminergici
rolpryna ep 8 mg
krka d.d., novo mesto - slovenia - clopidogrelum - compr. cu elib. prel. - 8 mg - agenti dopaminergici agonisti dopaminergici
speman comprimate
himalaya global holdings ltd - combinaţie - comprimate
hopveus
d&a pharma - oxibat de sodiu - substance withdrawal syndrome; alcohol abstinence - alte medicamente pentru sistemul nervos - substitution treatment for alcohol dependence within a framework of careful medical supervision along with continuous psychosocial support and social rehabilitation. treatment should be initiated only in patients resistant to existing interventions or in patients for whom existing therapies are contra-indicated or not recommended.
speman comprimate
himalaya global holdings ltd - combinaţie - comprimate
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasme de stomac - agenți antineoplazici - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
diaprel mr comprimate cu eliberare modificata 30 mg
les laboratoires servier - comprimate cu eliberare modificata - 30 mg
enap -hl 10 mg 12 5 mg 10 mg/12,5 mg comprimate
krka d.d., novo mesto - enalaprilum + hydrochlorothiazidum - comprimate - 10 mg/12,5 mg
enap -hl 20 mg 12 5 mg 20 mg/12,5 mg comprimate
krka d.d., novo mesto - enalaprilum + hydrochlorothiazidum - comprimate - 20 mg/12,5 mg